Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Sorrento is hiring someone to..."Lead marketing efforts to successfully commercialize Sorrento’s emerging diagnostics portfolio (COVISTIX™, COVITRACE™, COVITRACK™, RESPISTIX™)...

COVISTIX is a highly sensitive rapid antigen test for detecting SARS-CoV-2 that has demonstrated superior sensitivity at low levels of detection. Sorrento is also building a a robust pipeline of additional diagnostic tests, including COVITRACK (SARS-CoV-2 antibody serology test), COVITRACE (RT-LAMP colorimetric test for SARS-COV-2), and RESPISTIX (multiplexed SARS-CoV-2 and Flu A/B test)...

With Sorrento’s capability to rapidly screen and develop highly selective and potent antibodies, it is committed to being a leader in pandemic preparedness, bringing accurate, simple, and low-cost diagnostics to address current and future public health biothreats."

COVISTIX IS ONLY THE BEGINNING. The Mexican COVISTIX EUA is only the beginning. The 25 million shipment of COVISTIX test kits to Mexico is only the beginning. Mexico, Brazil, Latin America, Africa, India, Asia, the UK, Europe and even the US will need these tests! Billions of highly accurate, reasonably priced tests are needed NOW and for years to come!